Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.19.3
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash Flows From Operating Activities:    
Net Loss $ (12,236,000) $ (10,229,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 246,000 1,708,000
Subsidiary stock issued to consultant 104,000 0
Warrant issued to consultant 0 9,000
Change in fair value of warrant liabilities 0 (4,064,000)
Depreciation and amortization 182,000 207,000
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (600,000) 268,000
Right of use asset 86,000 0
Accounts payable 1,419,000 (1,141,000)
Accrued expenses 1,403,000 (41,000)
Accrued employee benefits (713,000) (640,000)
Lease Liability (159,000) 0
Deferred rent 0 (66,000)
Net Cash Used In Operating Activities (10,268,000) (13,989,000)
Cash Flows From Investing Activities:    
Net Cash Provided by (Used in) Investing Activities, Total 0 0
Cash Flows From Financing Activities:    
Proceeds from issuance ATM offering, net of issuance costs 0 6,422,000
Net Cash Provided By Financing Activities 0 6,422,000
Net decrease in cash (10,268,000) (7,567,000)
Cash and cash equivalents at beginning of period 28,918,000 17,116,000
Cash and cash equivalents at end of period 18,650,000 9,549,000
Noncash Financing Activities:    
Right of use asset from operating lease 538,000 0
Deemed dividends for beneficial conversion feature 585,000 0
In-kind dividends paid in preferred stock 185,000 181,000
Series B Preferred Stock [Member]    
Noncash Financing Activities:    
Conversion of Series B Preferred Stock $ 938,000 $ 0